1.8300
01-11月-24 10:56:12
15 分の遅延
株式
+0.0200
+1.10%
本日の幅
1.8300 - 1.8440
ISIN
N/A
ソース
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 10 2022 09:00:00 提供 Nasdaq GlobeNewswire